ACN - 101321555 Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

Resource Library

Research Ethics MonthlyAbout Us

ResourcesResearch Integrity(JAP) Japanese stem cell fraud leads to a new retraction – Retraction Watch (Adam Marcus | January 2019)

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

(JAP) Japanese stem cell fraud leads to a new retraction – Retraction Watch (Adam Marcus | January 2019)

 


View full details | Go to resource


Last March, we reported on the retraction of a 2017 paper in Stem Cell Reports by Kohei Yamamizu and colleagues for widespread fabrication of figures. Turns out the problems were at least five years older than that.

Yamamizu had received a pink slip from his institution, the Center for iPS Cell Research and Application (CiRA), which had put the blame for the misconduct squarely on his shoulders. (The director of the institute, Nobel winner Shinya Yamanaka, also took some of the blame in a public statement in which he said he bore “a strong responsibility for not having prevented research misconduct at our institute.”)

Yamamizu has a new retraction, but this time’s a bit different. Here’s the notice for the paper, “Protein Kinase A Determines Timing of Early Differentiation through Epigenetic Regulation with G9,” which appeared in Cell Stem Cell in June 2012 (Yamanaka was not a co-author on either study).  Although the statement acknowledges the internal investigation, it doesn’t mention misconduct or name Yamamizu:

Read the rest of this discussion piece



Resources Menu

Research Integrity


Human Research Ethics

0